Net profit of West Pharmaceutical Services under GAAP for 9 months of 2020 amounted to $247.8 million, an increase of 39.4% compared to $177.8 million in the previous year. Revenue increased by 14.5% to $1.567 billion from $1.369 billion a year earlier.
Net profit of West Pharmaceutical Services under GAAP for 9 months of 2020 amounted to $247.8 million, an increase of 39.4% compared to $177.8 million in the previous year. Revenue increased by 14.5% to $1.567 billion from $1.369 billion a year earlier. 
investor.westpharma.com
English (US) 